Published in Medical Letter on the CDC and FDA, April 24th, 2005
"It has been over a century since allergy skin testing and immunotherapy were first utilized. Both have withstood the test of time and numerous challenges such as cromolyn, antihistamines, and leukotriene modifiers that have threatened to make them obsolete to continue to play a prominent role in the diagnosis and treatment of the allergic patient. Considerable advances in the understanding immunotherapy mechanisms and effective allergen dosing as well as improved extract quality have been made in recent years," investigators...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.